Evidence map›Paper›PMID 25993006›Full record

ArticlePloS one2015

Minimally invasive electro-magnetic navigational bronchoscopy-integrated near-infrared-guided sentinel lymph node mapping in the porcine lung.

Hironobu Wada, Kentaro Hirohashi, Takashi Anayama, Takahiro Nakajima, Tatsuya Kato, Harley H L Chan, Jimmy Qiu, Michael Daly, Robert Weersink, David A Jaffray and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Sentinel lymph node biopsy for lung cancer.General thoracic and cardiovascular surgery · 2020
    Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Hironobu WadaDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kentaro HirohashiDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Takashi AnayamaDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Takahiro NakajimaDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tatsuya KatoDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Harley H L ChanGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
Jimmy QiuGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
Michael DalyGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
Robert WeersinkGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
David A JaffrayGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
Jonathan C IrishGuided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada; Department of Otolaryngology, Head and Neck Surgery/Surgical Oncology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Thomas K WaddellDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Shaf KeshavjeeDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Ichiro YoshinoDepartment of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kazuhiro YasufukuDivision of Thoracic Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada; Guided Therapeutics, TECHNA Institute, University Health Network, Toronto, Ontario, Canada.
University Health Network · CAToronto General Hospital · CAChiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) for sentinel lymph node (SN) mapping has been investigated in lung cancer; however, this has not been fully adapted for minimally invasive surgery (MIS). The aim of our study was to develop a minimally invasive SN mapping integrating pre-operative electro-magnetic navigational bronchoscopy (ENB)-guided transbronchial ICG injection and intraoperative NIR thoracoscopic imaging.

methodsA NIR thoracoscope was used to visualize ICG fluorescence. ICG solutions in a 96-well plate and ex vivo porcine lungs were examined to optimize ICG concentrations and injection volumes. Transbronchial ICG injection (n=4) was assessed in comparison to a traditional transpleural approach (n=3), where after thoracotomy an ICG solution (100 μL at 100 μg/mL) was injected into the porcine right upper lobe for SN identification. For further translation into clinical use, transbronchial ICG injection prior to thoracotomy followed by NIR thoracoscopic imaging was validated (n=3). ENB was used for accurate targeting in two pigs with a pseudo-tumor.

resultsThe ICG fluorescence at 10 μg/mL was the brightest among various concentrations, unchanged by the distance between the thoracoscope and ICG solutions. Injected ICG of no more than 500μ L showed a localized fluorescence area. All 7 pigs showed a bright paratracheal lymph node within 15 minutes post-injection, with persistent fluorescence for 60 minutes. The antecedent transbronchial ICG injection succeeded in SN identification in all 3 cases at the first thoracoscopic inspection within 20 minutes post-injection. The ENB system allowed accurate ICG injection surrounding the pseudo-tumors.

conclusionsENB-guided ICG injection followed by NIR thoracoscopy was technically feasible for SN mapping in the porcine lung. This promising platform may be translated into human clinical trials and is suited for MIS.

Indexed as

Electromagnetic FieldsAnimalsBronchiBronchoscopyFluorescenceIndocyanine GreenInjectionsLungLymph NodesPleuraSentinel Lymph Node BiopsySpectroscopy, Near-InfraredTime FactorsIndocyanine Green

Identifiers

PMID25993006
PMCPMC4438870
OpenAlexW1595863761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.